As the leading retail pharmacy in China, during this year's epidemic, JD Pharmacy not only ensured the circulation and supply of medicines in various places, but also solved the problems of follow-up visits and prescription renewal for patients with chronic diseases across the country, fully demonstrating JD Health's strong pharmaceutical supply chain capabilities. JD Pharmacy also pioneered the "professional service-oriented pharmaceutical and health retail" model. Based on its own team of pharmacists and doctors, it provides patients with professional and reasonable medication suggestions and safe medication guidance, and jointly creates the most trustworthy, safe and professional pharmaceutical and health service system.

In terms of risk management, JD Pharmacy combines the characteristics of Internet sales and pioneered the industry's "precise risk management system based on drug risk assessment", by dividing the existing platform drugs into six categories: X, A, B, C, D, and E according to risk levels. Among them, X-level drugs are banned from sale. Currently, they are prohibited from displaying and selling on the platform through sensitive word control and manual investigation. For example, Tylenol (hydroxycodone acetaminophen tablets) is an anesthetic drug. Another example is colchicine, which can be fatal due to overdose and is a Class B risk. Such drugs are restricted by the platform, and the prescription dosage is strictly controlled and the risks of medication are strongly reminded. In this way, after users purchase drugs at JD Pharmacy, the platform will remind them of the safety risks of different drugs through SMS, service number push and App information, so as to fully ensure the safety of users' medication.

It is understood that as early as 2016, when JD Pharmacy was launched, it officially put into operation the country's first COPC standard (customer service provider standard) and 100% online pharmacy service center for practicing pharmacists, providing consumers with medication consultation and guidance, ensuring safe and rational medication, and establishing consumers' correct medication concepts. After accumulating more than four years of mature experience, JD Pharmacy has polished and formed an intelligent "drug knowledge base" solution based on big data, artificial intelligence and other technologies to provide medication safety reminders and complement each other with doctors and pharmacists.

In the traditional medical model, doctors only rely on medical knowledge and their own experience to prescribe, and the resulting prescription standards are inconsistent, inefficient, and drug review is slow. JD Pharmacy has realized the provision of intelligent user risk suggestions to prescribing doctors through the background. After the user places an order, the doctor can obtain drug safety reminders in real time through the drug knowledge base, and pay attention to the contraindications, adverse reactions, interactions, etc. of the drug, so as to avoid adverse reactions caused by drug interactions.

It is based on the above series of measures that JD Pharmacy has established a drug safety standard that is higher than the industry regulatory standards and the industry average level. Regarding the importance of user safe medication, Jin Enlin, general manager of JD Health's medical department and head of strategy and investment, said bluntly: "Users attach much more importance to the reliability and safety of health than other products, and JD Health attaches unprecedented importance to drug safety."